TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$30.59
+0.25 (+0.82%)
Open$30.29
Previous Close$30.34
Day High$31.31
Day Low$29.54
52W High$36.03
52W Low$14.39
Volume—
Avg Volume128.0K
Market Cap566.45M
P/E Ratio—
EPS$-4.46
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+21.7% upside
Current
$30.59
$30.59
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 64.42M | 64.45M | 57.14M |
| Net Income | 9.98M | 8.55M | 7.27M |
| Profit Margin | 15.5% | 13.3% | 12.7% |
| EBITDA | 14.26M | 12.01M | 10.46M |
| Free Cash Flow | 6.92M | 8.94M | 6.74M |
| Rev Growth | +22.9% | -2.6% | -4.3% |
| Debt/Equity | 0.17 | 0.17 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |